ADAPTIN BIO, INC.
New Form D on file · 2026-01-05 · the record
What the record says
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 716 filings in Biotechnology, totalled by week. The dot is this raise, $1M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Use of proceeds, as written on the filing
Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering.
Company officers on record
On the filing as: Executive Officer, Director.
Michael Roberts is named as President and Chief Executive Officer on the Form D that ADAPTIN BIO, INC. filed with the SEC on 5 January 2026, one of 7 people that filing names.
Patrick Gallagher is named as Director on the Form D that ADAPTIN BIO, INC. filed with the SEC on 5 January 2026, one of 7 people that filing names.
J. Riehle is named as Director on the Form D that ADAPTIN BIO, INC. filed with the SEC on 5 January 2026, one of 7 people that filing names.
Anthony Zook is named as Director on the Form D that ADAPTIN BIO, INC. filed with the SEC on 5 January 2026, one of 7 people that filing names.
On the filing as: Executive Officer.
L. Hewitt is named as Chief Development Officer on the Form D that ADAPTIN BIO, INC. filed with the SEC on 5 January 2026, one of 7 people that filing names.
On the filing as: Executive Officer.
Timothy Maness is named as Chief Financial Officer on the Form D that ADAPTIN BIO, INC. filed with the SEC on 5 January 2026, one of 7 people that filing names.
On the filing as: Executive Officer, Director.
Simon Pedder is named as Executive Chairman on the Form D that ADAPTIN BIO, INC. filed with the SEC on 5 January 2026, one of 7 people that filing names.
7 people named on the filing — 4 holding an executive role and 3 as directors only.
Named as of the 2026-01-05 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
- 7 people named on the filing — 4 holding an executive role and 3 as directors only.
No investor is drawn from a Form D — the form states how many invested and never who.
The full profile
Source Check, INVEST, RECRUIT and Press Requests on ADAPTIN BIO, INC.
- Source Check — verify Michael J. Roberts's other claims against the registers that hold them.
- INVEST — size up this raise on the figures the filing states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with Michael J. Roberts for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist ADAPTIN BIO, INC.You get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind ADAPTIN BIO, INC.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. FoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.